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ABSTRACT 
We present the case of a 39 years old woman who was 
referred to our day hospital unit because of anxiety. 
The patient didn’t endorse any past psychiatric symp- 
toms except for an acute psychotic episode in August 
2010. In June 2010 she was diagnosed with hypothy- 
roidism (likely due to Hashimoto’s thyroiditis) and 
was started on Methilmazole 30 mg. Shortly after that 
she reported persecutory ideation and hallucinations 
which quickly progressed, until she was hospitalized 
in a psychiatric facility. Upon admittance her lab 
work revealed severe hypothyroidism. Methilmazole 
was suspended, she was started on Haloperidol, and 
the symptoms went into remission after four days. 
Despite the fact that she self discontinued Haloperidol 
shortly after discharge, she showed no sign of psy- 
chotic symptoms. While it is widely accepted that hy- 
pothyroidism can cause depressive symptoms, to the 
best of our knowledge very few cases of psychotic 
symptoms associated with this condition have been 
described. Based on the patient’s clinical history, on 
the rapid onset and remission of symptoms, on the lab 
values and on the doses of medication that were pre- 
scribed, we hypothesize that our patient’s psychotic 
episode was caused by iatrogenic hypothyroidism. 
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1. BACKGROUND 
The association between thyroid deficiency and psychi- 
atric presentation is not infrequent [1,2], but is com- 
monly overlooked as an etiology for behavioral, affective, 
and cognitive changes [3]. Traditionally, lethargy and 
lassitude were thought to be the typical psychiatric 
manifestations of hypothyroidism. Studies have shown, 
however, that 5% to 15% of myxedematous patients have 
some form of psychosis [4]. 
2. CASE REPORT 
We present a case of a 39 years old woman complaining 
of anxiety, who was referred to our Psychiatry Day Hos-
pital unit in September 2010. She said her anxiety had 
begun about a month earlier, denied substance abuse and 
any history of psychiatric disorders except for an acute 
psychotic episode in august 2010.  
General medical history was unremarkable except for 
hyperthyroidism (TSH 0.001 μU/mL; fT3 14.6 pg/mL; 
fT4 37 pg/mL) which first presented in June 2010, 10 
months after the birth of her first child. Anti thyroglobu- 
lin and anti thyroperoxidase antibodies at the time were 
133 UI/mL and 146 UI/mL. The subject was started on 
Methilmazole 30 mg on July 10th 2010 and, two weeks 
later, she developed auditory and visual hallucinations 
and persecutory delusions, which worsened until, on July 
31st, she was hospitalized in a psychiatric ward.  
Upon admittance she was alert and oriented, and pas- 
sively cooperant. General examination was normal ex- 
cept for bilateral swelling in the lower lymbs (which had 
begun 10 days earlier). She was euthymic but anxious 
because of visual and auditory hallucination (large faces 
with wigs laughing at her) and persecutory delusions. 
Lab work indicated severe hypothyroidism (TSH 87.8 
μU/mL, fT3 1.23 pg/mL and fT4 1.75 pg/mL). Methil- 
mazole was suspended and the patient was started on 
Haloperidol 10 mg. 
Four days later her symptoms remitted (at the time of 
discharge on August 4th she had no hallucinations nor 
delusions). She self discontinued Haloperidol one week 
later with no change in her mental status, and no recur- 
rence of psychotic symptoms. At the end of August she 
started having tremors, anxiety, mood swings and in- *Corresponding author. 
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somnia. Lab work indicated mild hyperthyroidism (TSH 
0.15 μU/mL, fT3 4.1 pg/mL, fT4 12 pg/mL).  
In mid September 2010 she was evaluated by means of 
the Hamilton Anxiety Rating Scale (HAM-A), Hamilton 
Depression Rating Scale (HAM-D), Brief Psychiatric 
Rating Scale (BPRS) and Scale for the Assessment of 
Positive Symptoms (SAPS). Her HAM-A score was 22, 
her HAM-D was 13, her BPRS score was 30 and her 
SAPS score was 2. Thyroid function was: TSH 0.02 
μU/mL, fT3 4.5 pg/mL, fT4 1.6 pg/mL; anti thyroglo- 
bulin and anti thyroperoxidase antibodies were 60 UI/mL 
and 86 UI/mL, respectively. Following an endocrino- 
logical consult the patient was diagnosed with Hashi- 
moto’s thyroiditis and was started on Methilmazole 10 
mg and Delorazepam 1 mg.  
In October 2010 she started having non-delusional 
persecutory thoughts which she recognized as “unrealis- 
tic”. Mood and affect were within the normal range, and 
she didn’t report any anxiety; she denied hallucinations. 
Thyroid function was: TSH 36 μU/mL, fT3 4 pg/mL, fT4 
2 pg/mL. Methilmazole was suspended, and the perse- 
cutory thoughts completely remitted after two weeks. In 
January 2011 the patient was euthymic, free of psychotic 
symptoms and only complained of anxiety. Her lab work 
indicated subclinical hyperthyroidism (TSH 0.03 μU/mL, 
fT3 4.3 pg/mL, fT4 16 pg/mL). Anti thyroglobulin and 
andithyroperoxidase antibodies were 57 and 42 UI/mL. 
Her HAM-A score was 15, her HAM-D score was 8, her 
BPRS score was 25 and her SAPS score was 0. Follow- 
ing endocrinological consult the patient was started on 5 
mg of Methilmazole. She was most recently evaluated in 
May 2011: lab work showed normal thyroid function, 
and there were no psychiatric symptoms.  
 
Table 1. Medication and psychiatric rating scales. 
 Jun  6th 
Jul  
7th 
Jul 
24th 
Jul  
31st 
Aug 
23rd 
Sep 
21st 
Nov 
15th
Jan 
3rd
Methilmazole (mg)  30 30 0    
Haloperidol (mg)   10     
SAPS    29  2  0 
BPRS    63  30  25
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Table 2. Thyroid profile. 
 Jun 6th
Jul 
7th
Jul 
24th 
Jul  
31st 
Aug 
23rd 
Sep 
21st 
Nov 
15th
Jan 
3rd
TSH (μU/mL) 0.0015 0.001  87 0.15 0.02 36.03 0.03
fT3 (pg/mL) 14.6 12  1.23 4.1 4.5 2 4.3
fT4 (pg/mL) 37 35  1.75 12 1.6 2 16
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Table 3. Anti-thyroid antibodies. 
 Jun 6th 
Jul 
7th
Jul 
24th
Jul 
31st 
Aug 
23rd 
Sep 
21st 
Nov 
15th
Jan 
3rd
Anti TG (UI/mL)  133   60  57 
Anti TPO (UI/mL)  146   86  42 
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3. DISCUSSSION 
While it is widely accepted that hypothyroidism can 
cause depressive symptoms, to the best of our knowledge 
only a few cases of psychotic symptoms associated with 
this condition have been described [3,5-10]. Based on the 
patient’s clinical history, on the rapid onset and remission 
of symptoms and on the doses of medication that were 
prescribed (Table 1), as well as the lab values (Tables 2 
and 3), we hypothesize that our patient’s psychotic epi-
sode was caused by iatrogenic hypothyroidism.  
 
REFERENCES 
[1] Benvenga, et al. (2003) Don’t forget the Thyroid in the 
aetiology of Psychoses. The American Journal of Medi- 
cine, 1, 115.  
[2] Roberts, et al. (2004) Hypothyroidism. Lancet, 363, 797- 
803. doi:10.1016/S0140-6736(04)15696-1 
Copyright © 2013 SciRes.                                                                              OJPsych 
L. Islam et al. / Open Journal of Psychiatry 3 (2013) 290-292 
Copyright © 2013 SciRes.                                                                             
292 
 OJPsych 
[3] Graham, et al. (2003) Hypothyroidism presenting as Psy- 
hcosis: Myxedema madness revisited. Journal of Clini- 
cal Psychiatry, 5, 260-266. 
[4] Hall, R.C. (1983) Psychiatric effects of thyroid hormone 
disturbance. Psychosomatics, 24, 7-18.  
doi:10.1016/S0033-3182(83)73255-X 
[5] Azzopardi, et al. (2010) Myxedema madness. British Me- 
dical Journal Case Reports. 
[6] Brewer, et al. (1969) Psyhcosis due to Acute Hypo- 
thyroidism during the administration of Charbimazole. 
The British Journal of Psychiatry, 115, 1181-1183.  
doi:10.1192/bjp.115.527.1181 
[7] Herridge, et al. (1969) Acute iatrogenic hypothyroid 
psychosis. British Medical Journal, 3, 154.  
doi:10.1136/bmj.3.5663.154  
[8] Lehrmann, et al. (2002) Myxedema Psychosis with grade 
II Hypothyroidism. General Hospital Psychiatry, 24, 
275-277. doi:10.1016/S0163-8343(02)00190-1 
[9] Logothetis, J. (1963) Psychotic behaviour as the indicator 
of adult myxoedema. The Journal of Nervous and Mental 
Disease, 136, 561-568. 
[10] Madakasira, S. and Hall, T.B. (1981) Capgras syndrome 
in a patient with myxedema. American Journal of Psy- 
chiatry, 138, 1506-1508.  
doi:10.1097/00005053-196306000-00008 
 
 
 
 
